Use of imaging in large vessel vasculitis: EULAR 2023 update

Managing Systemic Lupus Erythematosus: the latest EULAR recommendations

A non-pharma approach in systemic lupus erythematosus and systemic sclerosis

Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

The EULAR COVID-19 database and its insights into risk factors

Predictors of disease worsening in systemic sclerosis

Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab

The dose dependent effect of statins on osteoporosis

A prediction score for individuals at risk to develop rheumatoid arthritis

Prediction of radiographic progression using synovitis characteristics

Six-week treatment with low-dose prednisolone in patients with painful hand osteoarthritis

Highlights from ACR: guselkumab, ixekizumab and secukinumab in SpA

TULIP 2: Efficacy and Safety of Anifrolumab in Patients

TULIP 1 - highlights from the ACR meeting

Capture Hi-C reveals novel drug targets in rheumatic diseases

EULAR recommendations for the management of systemic lupus erythematosus

Musculoskeletal diseases on the rise worldwide and affecting developed countries the most

Three tips to get your manuscript published by ARD

Early inflammatory arthritis outcomes: what changed in the new millennium?